Dyax Corp. and CVie Therapeutics Announce Partnership to Develop and Commercialize KALBITORĀ® (ecallantide) for Hereditary Angioedema (HAE) and Other Angioedema Indications in China, Hong Kong and Macau 2013.02.08

 
 
  Download  


Ā© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD